She is a contributing editor and the column coordinator for Diabetes Under Control in AJN. Seley serves on the advisory boards of Abbott Diabetes Care, Amylin Pharmaceuticals, Sanofi-Aventis Pharmaceuticals, Pfizer Pharmaceuticals, Roche Diagnostics, Bayer Diabetes Care, Novo Nordisk Pharmaceuticals, and GlaxoSmithKline Pharmaceuticals. Katie Weinger is an investigator in behavioral and mental health research, director of the Center of Innovation in Diabetes Education and of the Office of Research Fellow Affairs at Joslin Diabetes Center and an assistant professor of psychiatry at Harvard Medical School, all in Boston. She has received a grant from the National Institutes of Health to study breaking down barriers to diabetes self-care (NIDDK60115). Diana J. Mason is editor-in-chief at AJN.